MAPT and Alzheimer disease: However, 77G7 suppressed AD O‐tau‐induced‐tau aggregation at the initial phase (0–15 h), but tau aggregates formed quickly at the next stage (15–48 h) and gradually reached the maximum at the end stage (48–72 h) with similar level of fluorescence intensity with mIgG group (Figure 3A).